{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-26-000148","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2026-11-13T13:35:29+00:00","discovered_at":"2026-11-13T13:40:00.359720+00:00","generated_at":"2026-11-13T13:40:24.265064+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tandem wins FDA 510(k) clearance for tubeless Tandem Mobi insulin pump; US launch planned for H1 2027","bullets":["FDA granted 510(k) clearance on November 12, 2026 for Tandem Mobi as a tubeless automated insulin delivery system.","New tubeless cartridge and infusion set converts the existing Tandem Mobi pump; infusion set cleared for up to 7 days of wear, cartridge for 3 days of use.","Mobi keeps Control-IQ+ hybrid closed-loop technology and is now cleared for both tubeless and tubed infusion, which Tandem calls the only pump offering both options.","Full US commercial launch of the tubeless cartridge and infusion set is planned for the first half of 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-26-000148","json":"https://secwatch.observer/filing/0001438133-26-000148.json","markdown":"https://secwatch.observer/filing/0001438133-26-000148.md","text":"https://secwatch.observer/filing/0001438133-26-000148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000148/0001438133-26-000148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000148/tndm-20261112.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-13T13:40:24.265064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}